Stifel analyst Jonathan Block raised the firm’s price target on Elanco (ELAN) to $17 from $16 and keeps a Buy rating on the shares. Stifel likes Elanco’s setup into 2Q25 results, and the stock remains the firm’s favorite idea within Animal Health, the analyst tells investors in a research note. Stifel expects operating margin to expand for the first time in four years in 2026.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELAN:
- Elanco Animal Health Amends Receivables Loan Agreement
- General Mills upgraded, Trade Desk downgraded: Wall Street’s top analyst calls
- Blair upgrades Elanco to Outperform on improved growth outlook
- Elanco upgraded to Outperform from Market Perform at William Blair
- Elanco Animal Health: Balanced Growth Prospects Amid Competitive Challenges and Innovation Uncertainties